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PseudogeneThe aryl hydrocarbon receptor (AHR) functions in higher organisms in development, metabolism and toxic
responses. Its Caenorhabditis elegans (C. elegans) ortholog, AHR-1, facilitates neuronal development, growth
and movement. We investigated the effect of AHR mutation on the transcriptional proﬁle of L4 stage C. elegans
using RNA-seq and quantitative real time PCR in order to understand better AHR-1 function at the genomic
level. Illumina HiSeq 2000 sequencing yielded 51.1, 61.2 and 54.0 million reads from wild-type controls,
ahr-1(ia03) and ahr-1(ju145) mutants, respectively, providing detection of over 18,000 transcripts in each
sample. Fourteen transcripts were over-expressed and 125 under-expressed in both ahr-1 mutants when
compared to wild-type. Under-expressed genes included soluble guanylate cyclase (gcy) family genes, some of
which were previously demonstrated to be regulated by AHR-1. A neuropeptide-like protein gene, nlp-20, and a
F-box domain protein gene fbxa-192 and its pseudogenes fbxa-191 and fbxa-193 were also under-expressed.
Conserved xenobiotic response elements were identiﬁed in the 5′ ﬂanking regions of some but not all of the gcy,
nlp-20, and fbxa genes. These results extend previous studies demonstrating control of gcy family gene expression
by AHR-1, and furthermore suggest a role of AHR-1 in regulation of a neuropeptide gene as well as pseudogenes.
© 2014 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
The aryl hydrocarbon receptor (AHR) is a eukaryotic transcription
factor that is activated by several classes of ligands in mammals, includ-
ing halogenated hydrocarbons, polycyclic aromatic hydrocarbons, and
polychlorinated biphenyls (Guenthner and Nebert, 1977; Nguyen and
Bradﬁeld, 2008). Upon ligand activation, AHR translocates to the nucleus,
heterodimerizeswith the aryl hydrocarbon receptor nuclear translocator
ARNT (Hoffman et al., 1990), binds to speciﬁc xenobiotic response ele-
ment (XRE) sequences in DNA (Denison et al., 1989) and recruits several
cofactors and general transcription factors (Hankinson, 2005) to regulate
transcription of genes.
While early studies focused on the role of AHR in xenobiotic detection
and detoxiﬁcation or mediation of toxicity, it is now recognized to have
far more diverse physiologic functions. Animal knockout studies havesa.heikkinen@uef.ﬁ
ars.goldsteins@uef.ﬁ
@uef.ﬁ (G. Wong).
Y-NC-ND license.demonstrated AHR's role in neuronal, immune, vascular, reproductive,
hepatic and hematopoietic development, as well as in neonatal survival,
metabolism of carbohydrates and fats and the regulation of growth, cell
cycle progression, apoptosis and tumorigenesis. Several classes of
endogenous ligands are known for the mammalian AHR of which the
6-formylindolo[3,2-b]carbazole (FICZ) binds with the highest afﬁnity
(Denison and Nagy, 2003, Nguyen and Bradﬁeld, 2008; Wincent et al.,
2012). Furthermore, the endogenous ligands can be metabolized by
enzymes induced by AHR, resulting in an autoregulatory loop (Wincent
et al., 2012). AHR can also act without a ligand, for example via disrup-
tion of cell–cell contact (Cho et al., 2004; Ikuta et al., 2004), activation
by modiﬁed low-density lipoprotein (McMillan and Bradﬁeld, 2007), or
via signaling through cAMP pathways (Oesch-Bartlomowicz et al.,
2005). Moreover, mitogen-activated protein kinase signaling cascades
modulate the activity of AHR (Puga et al., 2009). In addition to direct
actions, AHR can affect gene expression indirectly through cross-talk
with several other proteins including the retinoblastoma protein (Puga
et al., 2000; Marlowe and Puga, 2005; Puga et al., 2009) and other
transcription factors such as E2F1 (Watanabe et al., 2010), estrogen
and androgen receptors (Matthews and Gustafsson, 2006; Ohtake
et al., 2008), Nrf2 (Köhle and Bock, 2007), and NF-κB (Chen et al., 2011).
The ortholog of AHR in C. elegans, AHR-1, forms a complex with
the ARNT homolog AHA-1 to bind the XRE consensus sequence, but
does not bind 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or other
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C. elegansmutants lacking functional AHR-1, display alterations in neu-
ronal development (Huang et al., 2004; Qin and Powell-Coffman, 2004),
feeding behavior (Qin et al., 2006), larval development, movement, egg
laying, embryonic survival and defecation cycle (Aarnio et al., 2010).
Alterations in gene expression proﬁles suggest that AHR-1 plays a role
in metabolism, growth and development in L1 larval stage C. elegans
(Aarnio et al., 2010).
While AHR has been implicated in a wide range of physiologic
processes, the AHR-1 transcriptional targets in the nematode are not
well established beyond our limited microarray study (Aarnio et al.,
2010). Identiﬁcation of such targets would aid in understanding more
precisely the nature of AHR-1 action in a simple model organism. In
the present study, we aimed to assess transcriptomic differences
between L4 larval stage wild-type (N2) and ahr-1 mutant C. elegans
withRNA-seq andqRT-PCR to provide further insight into transcriptional
regulation under control of AHR-1 in C. elegans.
2. Material and methods
2.1. C. elegans strains and their growth
The C. elegans N2 wild-type strains and the ahr-1(ia03) (ZG24) and
ahr-1(ju145) (CZ2485) mutant strains were obtained from the
Caenorhabditis Genetics Center (Twin Cities, MN, USA). Nematodes
were grown in standard conditions as described by Brenner (1974).
Eggs were harvested from gravid nematodes with hypochlorite
treatment and grown to the L4 larval stage.
2.2. RNA-seq library preparation and sequencing
To focus our study, we studied the effect of AHR-1 on gene expres-
sion in only one developmental stage. L4 stage was chosen since in
this stage the animals have a large number of cells but do not yet contain
embryos that would contribute to the total RNA. Total RNAwas isolated
from L4 larval stagewild-type and ahr-1mutant animalswith TRIzol Re-
agent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's
instructions. Contaminating DNA was removed with Ambion TURBO
DNA-free kit (Applied Biosystems, Austin, TX, USA) as described in the
manual supplied by the manufacturer. mRNA libraries were made
using the RNA-seq Sample Preparation Kit according to the
manufacturer's instructions (Illumina, Inc., San Diego, CA, USA). The
Illumina HiSeq 2000 sequencing platform was used to obtain 51.1 mil-
lion, 61.2 million and 54.0 million 100-nucleotide paired-end reads for
N2 wild-type, ahr-1(ia03) mutant and ahr-1(ju145) mutant C. elegans
mRNAs, respectively.
2.3. RNA-seq data analysis
The quality of the reads was checked with FastQC. Reads containing
full adapter or primer sequences used in the sample preparation step
were searched but not removed. To ﬁnd possible reads arising from di-
etary E. coli, the reads were mapped to E. coli OP50 strain draft genome
(NCBI, ftp://ftp.ncbi.nih.gov/genomes/Bacteria_DRAFT/Escherichia_
coli_OP50_uid49051) with Bowtie 2.0.2 (Langmead et al., 2009)
allowing only exact matches. The parameters were set as follows: -k 1,
–score-min L, 0, 0, –minins 100, –maxins 300. The aligning reads were
not removed from further steps of the analysis. The reads were aligned
to C. elegans genome (version WS220, Release 62, Ensembl, ftp://ftp.
ensembl.org/pub/release-62/fasta/caenorhabditis_elegans/dna/) with
TopHat 1.3.1 (Trapnell et al., 2009) that uses Bowtie and SAMtools
0.1.16 (Li et al., 2009). Novel splice sites were not searched but
the reads that did not directly align to the genome were compared
against known splice sites obtained from the gene annotation ﬁle
Caenorhabditis_elegans.WS220.62.gtf (Ensembl, ftp://ftp.ensembl.org/
pub/release-62/gtf/caenorhabditis_elegans/). Parameter values wereset as follows: --mate-inner-dist 0, --mate-std-dev 50, --no-novel-juncs,
--transcriptome-max-hits 10, --max-multihits 10, --b2-N 1, --no-novel-
indels, -G Caenorhabditis_elegans.WS220.62.gtf. Differential gene expres-
sion analyses ahr-1(ia03) vs. wild-type and ahr-1(ju145) vs. wild-type
were performed using the Cuffdiff program of Cufﬂinks 1.3.0 (Trapnell
et al., 2010) and the ﬁle Caenorhabditis_elegans.WS220.62.gtf that con-
tains annotations for 45,343 predicted transcripts. Transcripts with
false discovery rate-corrected p-values b 0.05 and fold change N2 (or
b0.5), and FPKM value of N0 on both samples, were deﬁned as differen-
tially expressed. Enriched Gene Ontology terms (The Gene Ontology
Consortium et al., 2000) were found separately for the over-expressed
and under-expressed genes with DAVID Functional Annotation Tool 6.7
(Dennis et al., 2003).
2.4. qRT-PCR
Total RNA was isolated from four independent populations of wild-
type (N2), ahr-1(ia03) and ahr-1(ju145) mutant L4 stage C. elegans
with RiboPure™ Kit (Ambion, Austin, TX, USA). For each replicate,
0.5 μg of RNA was reverse-transcribed in a volume of 20 μl using
RevertAid H Minus M-MuLV First Strand cDNA Synthesis Kit (Thermo
Fisher Scientiﬁc, Waltham, MA, USA). The reverse transcription reac-
tions were diluted 1:6 with nuclease-free H2O; except for measuring
gcy-32 and gcy-37 the reactions were not diluted. Real-time PCR was
performed in a volume of 25 μl consisting of 12.5 μl of 2× Maxima™
SYBR Green qPCR Master Mix (Fermentas Life Sciences, Vilnius,
Lithuania), 0.3 μM (ﬁnal concentration) of forward and reverse primers
each, and 2.5 μl of the diluted reverse transcription reaction. The PCR
reactionswere performed on aMyiQ Single Color Real-Time PCR Detec-
tion System (Bio-Rad Life Sciences, Hercules CA, USA). The expression
fold changes were calculated using the concentration threshold (Ct)
and the 2−(ΔΔCt) method (Livak and Schmittgen, 2001). Oligo primer
sequences were purchased from Oligomer (Helsinki, Finland) and
their sequences were gcy-32 forward, 5′-CGA AAG CGG AAA GGA AAA
TA-3′; gcy-32 reverse, 5′-TCT CCC ATA CTT GAT CCT TGG T-3′; gcy-33
forward, 5′-TGA GCA GTT TGG ACG AAA GA-3′; gcy-33 reverse, 5′-CTG
CCA TAC TGG ATC GCT TT-3′; gcy-35 forward, 5′-GAA CGA AAC GAT
CGG AAA AG-3′; gcy-35 reverse, 5′-TCT CCT GCT GAC CAC CTT CT-3′;
gcy-36 forward, 5′-CAG GAT TTG AGG CAG GAA AA-3′; gcy-36 reverse,
5′-CCA TAC TTG CTC GCG TGT TA-3′; gcy-37 forward, 5′-GCT TCA CTC
GGA CAA TGG AA-3′; gcy-37 reverse, 5′-CTG ACC GTA ACC GGG TCA
AC-3′; nlp-20 forward, 5′-GGA CCA CAA GCT CAT GAA GG-3′; nlp-20 re-
verse, 5′-GTG CAA ATC GGG CAA ACT-3′; fbxa-191 forward, 5′-TGC AAT
TGT TTT GGA GAC GA-3′; fbxa-191 reverse, 5′-CCG ATA GGA ATG TCG
GAA AA-3′; fbxa-192 forward, 5′-GAA GCC CAT CGA GCT ATT CA-3′;
fbxa-192 reverse, 5′-ACG TCG ATT TGC TTG AAT CC-3′; fbxa-193 for-
ward, 5′-CTC CAA TTT TCG AGG CAT TC-3′; fbxa-193 reverse, 5′-AAG
AGA TAT TGC GTC CGG ATT-3′. Control: act-1 forward, 5′-TCG GTA
TGG GAC AGA AGG AC-3′; act-1 reverse, 5′-CAT CCC AGT TGG TGA
CGA TA-3′.
2.5. Search for putative XRE sites
5′ ﬂanking sequences of the nlp-20, gcy-32, gcy-33, gcy-35, gcy-36,
gcy-37, fbxa-191, fbxa-192 and fbxa-193 genes were obtained with the
BioMart MartView tool (Kasprzyk, 2011). The XRE core sequence
GCGTG was searched for exact matches in the 2000 bp 5′ ﬂanking
sequences with the Visualize tool of the POXO pipeline (Kankainen
et al., 2006).
3. Results
3.1. C. elegans AHR-1 and its mutant alleles
The C. elegans AHR-1 protein has similar basic helix–loop–helix
(bHLH), and Per–Arnt–Sim (PAS) A and B domains as the human
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encoded by exon 3 and the PAS domain likely involved in protein–
protein interactions and possibly ligand binding is encoded by exons 4
to 9. In addition, there is likely a transcriptional activation domain in
the carboxyterminus although it does not resemble the glutamine-rich
domain found in mammalian AHR (Powell-Coffman et al., 1998). Two
ahr-1 mutant strains were used with two different alleles, ia03 and
ju145. Of these, ia03 contains a 1517 bp deletion that removes exons 4
to 7 and results in a frameshift and a premature stop codon in exon 8
(Fig. 1B), whereas ju145 has a point mutation that leads to a premature
stop codon in exon 7 (Fig. 2C). The predicted gene products would
contain bHLH domains but not full PAS domains or carboxyterminal
transcriptional activation domains.3.2. Quality and alignment of RNA-seq reads to the C. elegans reference
genome
In the RNA-seq analysis, ~51.1 million reads were obtained for the
wild-type N2 sample, ~61.2 million reads for the ahr-1(ia03) mutant
sample and ~54.0 million reads for the ahr-1(ju145) mutant sample.
The mean quality score was above 32 at each read position and the
overall quality score was between 32 and 40 for the vast majority of
the reads (data not shown). There were few undetermined “N” bases
and all reads were of the same length (100 nt). The average GC content
matched the theoretical distribution in all of the samples. No over-
represented sequences were listed in the quality check with FastQC.
Some bases were enriched in a particular position of the reads.
From 0.13% to 0.18% of the reads contained a full adapter sequence
and 0.001% to 0.002% of the read pairs concordantly matched the ge-
nome of the food source Escherichia coli (E. coli). These reads were not
removed from the data analysis. TopHat removed 0.12% of the readsFig. 1. ahr-1 genemodel and predicted protein product of wild-type, ia03 and ju145 allele.
In the wild-type ahr-1 gene (A), part of the exon 3 encodes the bHLH domainwhereas the
PAS A domain is encoded by exon 4 and the PAS B domain by exons 7, 8 and 9. The ia03
mutant allele (B) contains a 1517 bp deletion 205 bp 5′ of exon 4 to 30 bp 5′ of exon 8
(Qin and Powell-Coffman, 2004). This results in a frameshift and a premature stop
codon. The possible resulting protein would contain the bHLH domain but only a small
part of the PAS B domain and no carboxyterminal domains beyond it. The ju145 allele
(C) has a C to T point mutation in exon 7 that results in a stop codon instead of the
codon for amino acid 302 (Huang et al., 2004). The possible resulting protein would
have a bHLH domain and PAS A domain but only a small part of PAS B domain and no
carboxyterminal domains.based on quality information. Of the reads, 85% to 88% aligned directly
with a maximum of one mismatch to the C. elegans “virtual tran-
scriptome” compiled based on the gene model annotation ﬁle given as
input (Table 1). A majority of these reads aligned to a single location
in the transcriptome. Readswithmore than 10 alignmentswere exclud-
ed from the following steps of the analysis. The reads not aligning
directly to C. elegans transcriptome were split in four 25 nt segments
by TopHat and aligned against genome using only annotated splice
sites. Reads with more than 10 alignments to splice junctions were
not included in the further steps of the analysis.
3.3. Transcriptomic changes in the ahr-1 mutant strains
Distribution of FPKM (fragments per kilobase of exon per million
fragments mapped) values for 45,343 known transcripts were calculat-
ed with Cufﬂinks. A total of 18,698 transcripts were detected in the N2
sample, 18,411 in the ahr-1(ia03) mutant sample and 18,603 in the
ahr-1(ju145) mutant sample. Expression levels of the transcripts were
between 0.001 and 1000 FPKM, a majority being between 0.1 and
1000 FPKM (Fig. 2A and B). Fourteen transcripts were over-expressed
and 125 transcripts under-expressed in both of the ahr-1mutants stud-
ied when compared to wild-type N2 according to the criteria of fold
change N2 or b0.5, FDR-corrected p-value of b0.05 and FPKM of N0 in
both samples (Fig. 2C and D, Supplementary ﬁles 1 and 2). In total, 193
transcripts were under-expressed and 184 transcripts over-expressed
in the ahr-1(ia03)mutant (Supplementary ﬁle 1) while 362 transcripts
were under-expressed and 27 transcripts over-expressed in the ahr-
1(ju145)mutant compared to wild-type N2 (Supplementary ﬁle 2).
The fourteen (14) most under-expressed and the fourteen (14)
over-expressed transcripts in both mutant strains are listed in Table 2.
Among the most under-expressed genes there were the soluble
guanylate cyclase genes gcy-32 and gcy-36, the neuropeptide-like
protein gene nlp-20 and the F-box A protein genes fbxa-191, fbxa-192
and fbxa-193 (Table 2). Among the over-expressed genes there were
the catalase genes ctl-1 and ctl-3, the insulin-related peptide gene
ins-35 and the collagen genes col-176 and dpy-3 (Table 2).
3.4. Conﬁrmation of the under-expression of nlp-20, gcy and fbxa genes
with qRT-PCR
Expression changes of the nlp-20 gene, ﬁve gcy family genes and
three fbxa family genes were measured with qRT-PCR (Fig. 3). nlp-20
and gcy-36 were under-expressed in both mutants according to both
RNA-seq and qRT-PCR. gcy-33 had b0.5 fold changes in both mutants
with both methods but was not determined as signiﬁcantly altered in
ahr-1(ia03) with RNA-seq. The fbxa-191, fbxa-192 and fbxa-193 genes
were signiﬁcantly and more than 2-fold under-expressed in both
mutants in RNA-seq but fbxa-191 and fbxa-193 could not be conﬁrmed
in the ahr-1(ju145) mutant with qRT-PCR. gcy-37 was signiﬁcantly
under-expressed in the ahr-1(ju145)mutant as determined with both
methods whereas in the ahr-1(ia03) mutant it was not detected with
RNA-seq and not signiﬁcantly altered with qRT-PCR. gcy-35was differ-
entially expressed in only the ahr-1(ju145)mutant. gcy-32was detected
in all four replicates of N2with qRT-PCR but in only two replicates of the
ahr-1(ia03)mutant and not at all in the ahr-1(ju145)mutant, probably
due to very low expression in themutants as suggested by the RNA-seq
data (Supplementary ﬁles 1 and 2). Although alterations could not be
conﬁrmed for every gene in both mutants the correlation between
RNA-seq and qRT-PCR results (r = 0.76) was similar as in Lee et al.
(2010) or Brooks et al. (2011).
3.5. Putative XREs in the promoter regions of the nlp-20, gcy and fbxa genes
The XRE core sequence GCGTG was searched in 2000 bp 5′ ﬂanking
sequences of the gcy, nlp-20 and fbxa genes. Putative XREswere found in
front of nlp-20, gcy-32, gcy-33, gcy-35, fbxa-191 and fbxa-192 (Fig. 4) but
Fig. 2. Expression levels (FPKM) of transcripts and differentially expressed genes in ahr-1 mutants vs. wild-type N2. Scatter plots of FPKM values of ahr-1(ia03) mutant vs. wild-type
(A) and ahr-1(ju145)mutant vs. wild-type (B) obtained in RNA-seq and calculated with Cufﬂinks. The lines correspond to fold changes of 2.0 (top), 1.0 (middle) and 0.5 (bottom). Red
dots represent transcripts with an FDR-corrected p-value of b0.05 (signiﬁcantly altered) while blue dots represent transcripts with an FDR-corrected p-value of N0.05 (not signiﬁcantly
altered). Transcriptswith FPKM of 0 in either condition are not shown. Under-expressed genes (C) and over-expressed genes (D) speciﬁcally in ahr-1(ia03)mutant (left), in bothmutants
(intersection) and speciﬁcally in ahr-1(ju145)mutant (right) compared to wild-type.
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a 54 bp difference in transcription start site and thus the XREs are in
slightly different locations for them. gcy-33 has three known isoforms.
The isoforms a and c have the same transcription start site but the tran-
scription of the isoform b starts 4594 bp downstream and the putative
XRE for gcy-33 isoform b is located in the 6th intron of the isoforms a
and c (Supplementary ﬁle 3). gcy-35 has four known isoforms. The tran-
scription of the isoforms b and c.2 starts 257 bp after that of isoform a.
The transcription of the gcy-35 isoform c.1 starts 6197 bp after that of
isoform a and the putative XREs are located in the 10th intron of iso-
forms a and b and in the 5′UTR of isoform c.2 (Supplementary ﬁle 3).
3.6. EnrichedGene Ontology terms among the differentially expressed genes
in the ahr-1 mutants
Enriched Gene Ontology (GO) terms among the 125 under-
expressed genes were found with DAVID (Supplementary ﬁle 4). The
only enriched GO Biological Process term on level 5 was “ProteinTable 1
Number of reads in different steps of the RNA-seq data analysis.
Wild-type N2
Total no. reads
Left 51,093,813
Right 51,093,813
Reads aligned to virtual transcriptome
Left 44,378,944 (86.9%)
Right 44,998,895 (88.1%)
Reads in the ﬁnal output ﬁle 79,767,834 (78.1%)
Alignments in the ﬁnal output ﬁle 83,485,923
The percentages of left and right reads are calculated from the numbers of original left and right
the total number of reads in the beginning (left + right reads).modiﬁcation process” involving kinase and phosphatase genes. Over-
represented GO terms were also found for the 14 over-expressed
genes including “Cellular response to reactive oxygen species” and
“Hydrogen peroxide catabolic process”, and each term involved only
the two catalase genes ctl-1 and ctl-3 (Supplementary ﬁle 4).
4. Discussion
4.1. A large number of genes are under-expressed in the ahr-1 mutant
C. elegans
Thereweremore under-expressed genes thanover-expressed genes
in the ahr-1mutant compared to wild-type L4 stage C. elegans (Fig. 2).
This is consistent with our previous microarray study that found 238
over-expressed genes and 324 under-expressed genes in ahr-1mutant
L1 stage (Aarnio et al., 2010). However, the differentially expressed
genes in ahr-1 mutants in this RNA-seq study in L4 stage were quite
different than in our previous microarray study in L1 stage. This isahr-1(ia03) ahr-1(ju145)
61,237,752 54,013,714
61,237,752 54,013,714
52,078,793 (85.0%) 46,569,835 (86.2%)
52,995,785 (86.5%) 47,134,403 (87.3%)
93,807,949 (76.6%) 86,625,445 (80.2%)
96,875,412 86,825,445
reads, respectively. The percentages of the reads in theﬁnal output ﬁle are calculated from
Table 2
Fourteen most under-expressed and the fourteen over-expressed genes in both ahr-1mutants compared to wild-type.
Gene ID Gene name
(if available)
Fold change
ahr-1(ia03)/N2
Fold change
ahr-1 (ju145)/N2
FDR-corrected p-value
ahr-1(ia03) vs. N2
FDR-corrected p-value
ahr-1(ju145) vs. N2
F41D3.14 0.02 0.10 1.3 × 10−2 3.0 × 10−2
F57G4.8 fbxa-192 0.03 0.29 0.0 2.7 × 10−6
F57G4.4 fbxa-191 0.04 0.29 8.6 × 10−9 3.7 × 10−4
F59A1.9 fbxa-193 0.04 0.46 4.0 × 10−11 2.2 × 10−2
C06B3.8 gcy-32 0.05 0.07 8.9 × 10−6 1.4 × 10−5
F45E4.8 nlp-20 0.06 0.07 0.0 0.0
Y76G2A.2 0.11 0.35 6.2 × 10−4 4.5 × 10−2
C06A5.10 0.11 0.35 6.2 × 10−4 4.5 × 10−2
C46E1.2 gcy-36 0.13 0.11 6.1 × 10−4 1.7 × 10−5
Y116A8C.465 0.13 0.17 1.3 × 10−2 3.0 × 10−2
R07D5.2 0.16 0.26 1.5 × 10−3 1.9 × 10−3
B0513.12 0.17 0.28 7.3 × 10−4 4.9 × 10−3
Y67D8B.3 0.18 0.32 1.5 × 10−2 3.0 × 10−2
ZK1098.9 0.19 0.40 2.4 × 10−6 3.4 × 10−3
– – – – – –
EGAP7.1 dpy-3 3.10 2.02 3.2 × 10−7 1.0 × 10−3
K02E7.10 3.22 2.38 3.1 × 10−2 4.9 × 10−2
F33H12.7 3.31 2.43 1.5 × 10−4 3.0 × 10−2
ZC373.7 col-176 3.36 2.45 1.8 × 10−9 2.2 × 10−6
Y54G11A.13 ctl-3 3.36 3.01 1.2 × 10−5 2.4 × 10−6
T25G12.11 3.51 2.76 4.6 × 10−2 4.6 × 10−2
ZC84.1 3.68 2.59 1.5 × 10−2 3.2 × 10−2
Y105C5A.13 3.91 2.20 1.4 × 10−3 4.7 × 10−2
F44G3.2 3.94 2.59 1.1 × 10−8 2.0 × 10−5
K07D4.4 4.02 3.09 2.7 × 10−2 2.9 × 10−2
C08G9.2 4.27 2.69 3.8 × 10−3 2.3 × 10−2
Y54G11A.6 ctl-1 4.51 4.10 3.6 × 10−10 1.6 × 10−12
K02E2.4 ins-35 7.90 4.47 4.8 × 10−6 3.0 × 10−4
C36C5.14 14.11 8.35 2.2 × 10−4 4.3 × 10−3
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between developmental stages in C. elegans (Agarwal et al., 2010).
Moreover, gene expression proﬁle comparisons between AHR knockout
andwild-type animal tissues report dozens to thousands of differential-
ly expressed genes depending on the criteria (Boutros et al., 2009; Jux
et al., 2009; Sartor et al., 2009; Boutros et al., 2011; Jux et al., 2011).
In order to observe the effects of a loss of function ahr-1mutant, we
used two available alleles (ia03) and (ju145). It is possible that they are
translated into truncated proteins, that still contain theDNAbinding do-
main and a PAS domain that binds ligands, but they lack any possible
carboxyterminal transcriptional activation domains (Fig. 1). While we
have no evidence that the truncated proteins exist, if they are translated,
it is possible that they bind XRE elements (or possibly other response
elements) without activation and lead to a repressor-like function.Fig. 3. Fold changes of ahr-1mutant/wild-typeN2 of selected transcripts asmeasuredwith RNA-
standard deviations. *, t-test p-value b 0.05; †, p-value b 0.01; ‡, p-value b 0.001. The p-values in
ahr-1mutant/wild-type. gcy-32 was not detected in the ahr-1(ju145)mutant in qRT-PCR, andTherefore, we cannot completely rule out that our studies leave the
possible repressor roles of AHR-1 intact while the data we observe are
derived only from the loss of activation role. This may explain the rela-
tively large number of genes differentially expressed in only onemutant
strain.4.2. gcy family
Our ﬁnding that gcy family genes were signiﬁcantly under-
expressed is in agreement with previous studies showing gcy-32,
gcy-34, gcy-35 to a greater extent, and gcy-36 and gcy-37 to a lesser ex-
tent, as regulated in ahr-1mutants via a series of promoter-GFP fusion
constructs (Qin and Powell-Coffman, 2004; Qin et al., 2006). The roleseq and qRT-PCR. The qRT-PCRwas performed for four biological replicates. Errors indicate
RNA-seq are FDR-corrected. The fold changeswere transformed by log2 of the fold change
gcy-37 was not detected in the ahr-1(ia03)mutant in RNA-seq.
Fig. 4. Locations of putative XREs in 2000 bp upstream sequences of under-expressed genes. The putative XRE core sequences (GCGTG) aremarked as green arrows. Arrows pointing right
are XREs in the same strand and orientation as the transcript, whereas arrows pointing left are XREs in the opposite strand and orientation than the transcript. The crooked arrow on the
right indicates a transcription start site.
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genes, speciﬁcally members of the gcy family and npr-1.
Our results indicate that transcriptional proﬁling, using RNA-seq of
whole animals, can reveal transcriptional changes at the cellular level.
While promoter-GFP analyses indicate expression of gcy genes in 2–20
neurons, we were able to observe diminution of RNAs puriﬁed from
whole animals containing approximately 1000 cells, in ahr-1 mutants.
This sensitivity of whole animal RNA-seq to detect differences in expres-
sion, even for genes expressed in only a few cells, is in agreement with a
previous study from our laboratory that found differential expression of a
cyp gene following ethanol exposure, a gene thatwas expressed in a small
subset of intestinal cells (Peltonen et al., 2013). These ﬁndings thusprovide conﬁdence that whole C. elegans RNA-seq studies may be useful
to ﬁnd signiﬁcant RNA level changes even for those affecting a few cells.
4.3. nlp-20
The nlp-20 gene represents one of the highly under-expressed genes
in ahr-1 mutants with XRE elements on its promoter. NLP-20 is a
neuropeptide-like protein whose receptor is unknown and its knock-
down by RNAi leads to embryonic lethality (Sönnichsen et al., 2005).
nlp-20 is expressed in 4 head neurons, 4 tail neurons, 1 pharyngeal neu-
ron, spermatheca, and intestine (Nathoo et al., 2001). Since npr-1was
previously found to be regulated by AHR-1 and plays a key role in
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of NPR-1. It seems highly unlikely, however, since the known ligands of
NPR-1 are FLP-18 and FLP-21 that are FMRFamide related peptides, a
neuropeptide class different than NLPs (Li et al., 1999; Rogers et al.,
2003). It is possible that other neuropeptide receptors exist that medi-
ate aggregation behavior. More likely NLP-20 is part of a neuronal path-
way that mediates other aspects of AHR function such as neuronal
speciﬁcation and development. It is interesting that in our previous mi-
croarray study of L1 stage ahr-1mutants, nlp-30 was among the most
under-expressed genes (Aarnio et al., 2010) further suggesting a role
for AHR-1 in neuropeptide regulation.
4.4. fbxa genes
A novel and more tantalizing role for AHR-1 transcription is the
regulation of proteins that contain F-box motifs. fbxa-191 and fbxa-193
are pseudogenes whereas fbxa-192 is protein-coding. Pseudogenes,
noncoding RNAs derived from functional genes, were originally
considered to be products of junk DNA and to eventually mutate to
background DNA due to lack of purifying selection (Balakirev and
Ayala, 2003). More recent studies suggest that they may be functional
as regulators of RNA expression through antisense, siRNA, and miRNA
decoy action (Pink et al., 2011). The coordinate regulation of three
very similar fbxa genes of which two are pseudogenes and one is protein
coding is reminiscent of a recent report detailing the phosphatase and
tensin homolog (PTEN) tumor suppressor geneunder regulatory control
of one of its pseudogenes PTENpg1 (Johnsson et al., 2013). The extent to
which AHR-1 controls non-coding RNA expression remains to be deter-
mined butwe have observed several other non-coding RNAs on our lists
of differentially expressed genes in RNA-seq (data not shown).
4.5. Putative XRE elements
The nlp-20 gene aswell as some of the gcy family genes displaymul-
tiple XRE sites (Fig. 4).Wedid not detectGCGTGpatterns in the2000 bp
ﬂanking sequence of gcy-36 but found one in its 5′UTR (data not shown)
which likely is the one found earlier by Qin et al. (2006). Also the
fbxa-191 and fbxa-192 genes have putative XRE sites in their 2000 bp
5′ ﬂanking sequences (Fig. 4) whereas the closest putative XRE site for
fbxa-193 is 2164 bp upstream of the transcription start site (data not
shown).
In the study by Qin et al. (2006), a gcy-35 promoter of 1250 bp as
well as a gcy-36 promoter of 1172 bp, were sufﬁcient for GFP transgene
expression in wild-type and the expression was diminished in ahr-1
mutants. Similarly in this study, nlp-20 promoter of ~1.8 kbp was sufﬁ-
cient for GFP transgene expression in the presence of wild-type ahr-1,
and the expression was signiﬁcantly reduced in the ahr-1(ia03)mutant
(Fisher exact test p-value b 0.05). In nlp-20::GFP transgenic crosses to
ahr-1 mutant background, 28 out of 38 lines carrying at least one
wild-type ahr-1 allele expressed detectable levels of GFP under the
nlp-20 promoter, whereas only 2 of the 8 lines homozygous for the
ahr-1(ia03)mutant allele expressed GFP (data not shown). This obser-
vation, as well as that of Qin et al. (2006), suggests that AHR-1 induces
gcy-35, gcy-36 and nlp-20 through the promoters used. However, AHR-1
does not appear to bind to the putative XRE sites in the gcy-35 and gcy-
36 promoters, since point mutation of the AHR-1 binding half-site did
not diminish the expression of these genes in the presence of functional
AHR-1 (Qin et al., 2006).
4.6. Over-expressed genes in ahr-1 mutants
We found far fewer over- than under-expressed genes in our study
(14 vs. 125). Gene ontology analysis suggested that thesemay be related
to oxidative stress, as exempliﬁed by the two catalase genes ctl-1 and ctl-
3 (Supplementary ﬁle 4). AHR has been previously associated with the
induction of genes in the oxidative stress pathway in higher organisms(Nebert et al., 2000; Dalton et al., 2002). However, in this study we
ﬁnd regulation of only two genes in the pathway, and they are over-
expressed. The over-expression was modest (~3–4.5 fold) and this
was also conﬁrmed in qRT-PCR in ctl-3 (1.3–1.8 fold, data not shown).
Moreover, over-expression of genes in a transcription factor mutant is
suggestive of a repressive rather than activating role. We also did not
see a signiﬁcant increase in catalase activity in either ahr-1(ia3) or ahr-
1(ju145) alleleswhen compared to N2 (data not shown), so these differ-
encesmay be only transcriptional. In the absence of strong data suggest-
ing activation of oxidative stress pathways via ahr-1 in C. elegans, it is
therefore possible that the role of AHR in oxidative stress observed in
higher organisms has evolved over time separately from C. elegans.5. Conclusions
We measured the transcriptome proﬁles of ahr-1mutant and wild-
type C. elegans at the L4 larval stage. The results suggest that AHR-1 reg-
ulates the expression of genes related to functions previously described
for AHR-1 such as aggregation behavior, neuronal speciﬁcation and de-
velopment. We also demonstrate regulation of a novel set of genes
encoding a neuropeptide-like protein, F-box motif proteins and their
pseudogenes. Coupled with the already demonstrated role of AHR in
fat metabolism, hematopoietic function, and immune system develop-
ment, we show here molecular details of the control AHR-1 exerts on
gene expression at the genomic level, and further expand an already
broad and expansive the role of AHR in biological systems.Abbreviations
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